Advisor Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$9.99M Buy
76,015
+1,285
+2% +$149K 0.07% 238
2019
Q3
$8.36M Buy
74,730
+3,658
+5% +$407K 0.06% 265
2019
Q2
$7.88M Buy
71,072
+4,816
+7% +$567K 0.06% 276
2019
Q1
$8.6M Buy
66,256
+567
+0.9% +$68.9K 0.07% 237
2018
Q4
$7.61M Sell
65,689
-3,105
-5% -$347K 0.07% 222
2018
Q3
$7.38M Buy
68,794
+11,434
+20% +$1.14M 0.07% 226
2018
Q2
$4.9M Sell
57,360
-8,163
-12% -$670K 0.07% 251
2018
Q1
$5.07M Buy
65,523
+14,238
+28% +$1.15M 0.07% 242
2017
Q4
$4.33M Sell
51,285
-32,250
-39% -$2.74M 0.06% 299
2017
Q3
$7.15M Buy
83,535
+8,647
+12% +$709K 0.11% 172
2017
Q2
$6.16M Buy
74,888
+7,340
+11% +$599K 0.11% 193
2017
Q1
$5.68M Buy
67,548
+8,719
+15% +$698K 0.11% 189
2016
Q4
$4.33M Buy
58,829
+18,566
+46% +$1.38M 0.1% 228
2016
Q3
$3.23M Buy
40,263
+2,450
+6% +$196K 0.08% 282
2016
Q2
$2.97M Buy
+37,813
New +$2.85M 0.08% 275

Other funds holding LLY

Advisor Group's LLY Position: Q4 2019 in Review

Advisor Group increased its Eli Lilly (LLY) stake by 1.7% in Q4 2019, buying an estimated $149K and bringing the position to 76,015 shares worth $9.99M. The position accounts for 0.07% of the portfolio, ranked #238.

Advisor Group first reported a position in LLY in Q2 2016 and has held it in 15 quarters since. 1,672 funds tracked by Wall St. Rank hold LLY as of Q4 2019.

  • Advisor Group held 76,015 shares of Eli Lilly worth $9.99M as of Q4 2019.
  • Advisor Group bought 1,285 Eli Lilly shares in Q4 2019, an estimated $149K.
  • Eli Lilly made up 0.07% of Advisor Group's portfolio in Q4 2019, its #238 holding.
  • Advisor Group first reported a position in Eli Lilly in Q2 2016 and has held it in 15 quarters since.
  • 1,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.